Medroxyprogesterone: study card

Medroxyprogesterone — Progestin (injectable contraceptive). Study the mechanism, listed uses and warnings from the US label on one sourced card.

Generic name
Medroxyprogesterone
Class
Progestin (injectable contraceptive)
Mechanism
Inhibits gonadotropin secretion, preventing follicular maturation and ovulation, and thickens cervical mucus.
Used for
Prevention of pregnancy
Common side effects
Menstrual irregularities; Weight gain; Headache; Abdominal pain / discomfort; Nervousness
Boxed warning
The injectable contraceptive can cause substantial bone-density loss that increases with duration and may not fully recover. Use for more than two years is not recommended unless other contraceptive options are inadequate.
Warnings
Thromboembolic disorders; Breast cancer risk; Meningioma
Interactions
Enzyme inducers incl. CYP3A4 (e.g., rifampin)

Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.

Read the source label ↗

Label date: 20260904 · For learning, not clinical decisions. US label and brand information; always consult the current source.

Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.

Pronunciation

Medroxyprogesterone: me-DROX-ee-proe-JES-ter-ohn

Pronunciation is shown for the US English generic name.

Body system

Women's health · 12 Drug cards

Compare with related cards

Norgestimate / Ethinyl Estradiol

Same body system: Women's health

Mechanism: Primarily suppresses ovulation; possible additional mechanisms include cervical-mucus changes that inhibit sperm penetration and endometrial changes that reduce implantation likelihood.

On both cards: Used for — Prevention of pregnancy · Warnings — Thromboembolic disorders

Only on the Norgestimate / Ethinyl Estradiol card: Common side effects — Headache / migraine; Abdominal pain; Breast tenderness; Nausea; Irregular uterine bleeding · Warnings — Liver disease / jaundice; Hypertension · Interactions — CYP3A4 inducers (reduced efficacy)

Norethindrone

Same body system: Women's health

Mechanism: Suppresses ovulation in about half of users, thickens cervical mucus, blunts LH/FSH peaks and alters the endometrium.

On both cards: Used for — Prevention of pregnancy · Common side effects — Headache

Only on the Norethindrone card: Common side effects — Menstrual irregularity; Breast tenderness; Nausea; Dizziness · Warnings — Known or suspected pregnancy (contraindicated); Breast carcinoma (contraindicated); Liver tumors or acute liver disease · Interactions — CYP3A4 inducers (reduced efficacy)

Levonorgestrel / Ethinyl Estradiol

Same body system: Women's health

Mechanism: Prevents pregnancy primarily by suppressing ovulation.

On both cards: Used for — Prevention of pregnancy · Common side effects — Headache

Only on the Levonorgestrel / Ethinyl Estradiol card: Common side effects — Menorrhagia; Nausea; Dysmenorrhea; Breast tenderness · Warnings — Thrombotic and thromboembolic events; Liver disease; Hypertension · Interactions — Enzyme inducers (reduced efficacy)

An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.

Boxed warnings on related cards

Other cards with a boxed warning in this body system (Women's health): Norethindrone / Ethinyl Estradiol, Estradiol (transdermal), Norgestimate / Ethinyl Estradiol, Progesterone, Estradiol (topical), Levonorgestrel / Ethinyl Estradiol, Drospirenone / Ethinyl estradiol, Etonogestrel / Ethinyl Estradiol, Desogestrel / Ethinyl Estradiol, Norelgestromin / Ethinyl Estradiol